Delivery Order SPE2DB20D2104-SPE2DB25FMHWF

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,783.70, is for the delivery of ISOTRETINOIN 40 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through March 6, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,241.00, is for the delivery of ISOTRETINOIN 40 MG CAPSULE 30S. It is a firm fixed-price contract with a period of performance ending on January 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a for-profit organization registered in the System for Award...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of isotretinoin 40 mg capsules. The $1,142.31 firm fixed price contract has a completion date of March 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISOTRETINOIN 40 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $1,746.56 and a completion date of January 15, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a $17,755.89 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ISOTRETINOIN 40 MG CAPSULE 30S. The contract has an ultimate completion date of August 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these pharmaceutical products to support military treatment facilities and other federal healthcare programs. The contract is not associated with a set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,585.60, is for the supply of 4566773318 ISOTRETINOIN 40 MG CAPSULE 30S to support federal government healthcare programs. The contract has an ultimate completion date of December 23, 2024 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $1,911.54 firm fixed-price contract is for the supply of ISOTRETINOIN 30 MG CAPSULE 10S, a pharmaceutical product, with a performance period through May 9, 2024. Amerisourcebergen holds a much larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,112.04 and is a firm fixed-price delivery order for the supply of ISOTRETINOIN 40 MG CAPSULE 30S, a pharmaceutical product. The award has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ISOTRETINOIN 30 MG CAPSULE 30S, a generic pharmaceutical product, with a total ceiling value of $7,212.98 and an ultimate completion date of February 21, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ISOTRETINOIN 40 MG CAPSULE 30S, a generic pharmaceutical product, with a ceiling value of $19,426.36 and a completion date of December 15, 2023. The contract is not designated as a set-aside and was awarded on an open competition basis. Amerisourcebergen holds a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMHWF
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,089.15 firm fixed-price contract is for the supply of ISOTRETINOIN 40 MG CAPSULE 30S, with a period of performance running through February 12, 2025. The contract is not set aside for any specific business type.

AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical commodities.

Generated 5/13/25, 10:13 AM